ClearPoint Neuro CLPT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$29.07M-39.8% | -$25.54M-35.0% | -$23.14M-27.5% | -$22.22M-23.6% | -$20.79M-0.8% | ||
| $797K-5.1% | $814K-16.9% | $805K-12.8% | $1M+22.8% | $840K+13.5% | ||
| $8.49M+16.1% | $8.18M+18.4% | $7.9M+17.1% | $7.78M+21.1% | $7.31M+16.5% | ||
| $125K+247% | $83K+62.7% | $60K-9.1% | $43K-25.9% | $36K-37.9% | ||
| —— | —— | —— | —— | —— | ||
| $3.13M+160% | $268K-77.8% | $552K-57.5% | $1.21M+24.8% | $1.21M+55.8% | ||
| $306K+140% | $103K+114% | -$293K+79.3% | -$1.55M-85.7% | -$768K+59.1% | ||
| —— | —— | —— | —— | $1.15M— | ||
| —— | —— | $522K+96.2% | -$420K-1,255% | -$265K-182% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| -$1.17M-25.4% | -$1.01M-16.5% | -$950K-13.5% | -$939K-8.8% | -$932K-19.5% | ||
| -$25.7M-128% | -$23.9M-167% | -$13.09M-47.5% | -$11.17M-17.9% | -$11.28M+5.0% | ||
| $984K+115% | $522K+89.8% | $736K+2,130% | $549K+114% | $458K-20.9% | ||
| —— | $1.14M— | $852.75K— | $568.5K— | $284.25K— | ||
| $153K+133% | $615K+324% | -$736K— | -$549K— | -$458K— | ||
| —— | —— | —— | —— | —— | ||
| $2.54M+61.2% | $1.86M+338% | $1.75M+363% | $1.81M+344% | $1.58M+343% | ||
| $49.7M— | $50.18M— | $30.65M— | —— | —— | ||
| —— | —— | —— | $8.88M+39.1% | -$22.97M— | ||
| $1.43M+386% | $908K+89.2% | $490K-26.8% | $282K-62.1% | $295K-60.6% | ||
| $69K+11.3% | $69K+11.3% | $90K+120% | $33K-19.5% | $62K— | ||
| $125K+247% | $83K+62.7% | $60K-9.1% | $43K-25.9% | $36K-37.9% | ||
| —— | —— | —— | —— | $0— | ||
| -$1.17M-25.4% | -$1.01M-16.5% | -$950K-13.5% | -$939K-8.8% | -$932K-19.5% | ||
| $266K— | $195K— | —— | —— | —— | ||
| —— | —— | $522K+96.2% | -$420K-1,255% | -$265K-182% | ||
| $1.43M— | $908K— | $490K— | $172K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$1.17M-25.4% | -$1.01M-16.5% | -$950K-13.5% | -$939K-8.8% | -$932K-19.5% | ||
| -$26.68M-127% | -$24.42M-165% | -$13.82M-55.2% | -$11.72M-20.4% | -$11.74M+5.8% | ||
| -$26.68M-127% | -$24.42M-165% | -$13.82M-55.2% | -$11.72M-20.4% | -$11.74M+5.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ClearPoint Neuro generate?
- ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
- What is ClearPoint Neuro's free cash flow?
- After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
- Where does ClearPoint Neuro's cash flow data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
